Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015–2016 epidemic season in Israel

2017 ◽  
Vol 88 ◽  
pp. 12-16 ◽  
Author(s):  
Rakefet Pando ◽  
Yaron Drori ◽  
Nehemya Friedman ◽  
Aharona Glatman-Freedman ◽  
Hanna Sefty ◽  
...  

2018 ◽  
Vol 63 (2) ◽  
pp. 61-68 ◽  
Author(s):  
D. K. Lvov ◽  
E. I. Burtseva ◽  
E. S. Kirillova ◽  
L. V. Kolobukhina ◽  
E. A. Mukasheva ◽  
...  

The article presents the features of the influenza virus circulation for the period from October 2016 to May 2017 in some territories of Russia collaborating with the D.I. Ivanovsky Institute of Virology, Federal State Budgetary Institution “N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology”, Ministry of Health of the Russian Federation. One of the 2016-2017 season’s peculiarities in Russia and countries of the Northern hemisphere was the earlier start of an increase in ARD morbidity with peak indexes reached towards the end of December 2016 - January 2017. First, influenza A(H3N2) virus was predominant; then, it was followed by influenza B virus activity observed until the end of the season. The indexes of morbidity were higher than in the previous season, while the rates of hospitalization and mortality were lower, lethal cases being detected in persons 65 years old and older. Epidemic strains of influenza A(H3N2) virus belonged to 3c.2a genetic group, reference strain A/Hong Hong/4408/2014, and its subgroup 3c.2a1, reference A/Bolzano/7/2016, that are antigenically similar. Strains of influenza B virus were antigenically similar to the B/Brisbane/60/2008 vaccine virus. Strains were sensitive to oseltamivir and zanamivir. The share participation of non-influenza ARI viruses was similar to preliminary epidemic seasons. WHO has issued recommendations for influenza virus vaccines composition for 2017-2018 for the Northern hemisphere.



2019 ◽  
Vol 9 (02) ◽  
Author(s):  
Ilham A Bunyan ◽  
Shokry Faaz ◽  
Hala H Ali

In this study, (17) pericardial effusion specimens and blood samples were obtained from hospitalized patients diagnosedwith pericardial effusion at Marjan Teaching Hospital, AL-Sader Teaching Hospital and Ibn-AL-Biatar Cardiovascular Center with age range between (2-77) years old from both sexes, 6(35.30%) male and 11(64.70%) of them were female. The period of collection were extended from July (2018) to January (2019). A total of (17) samples from hospitalized patients with pericardial effusion were included in this study, only 9(52.9%) patients with positive bacterial blood culture media, 7(77.8%) from female and 2(22.2%) from male, and 10(58.8%) patients with positive bacterial pericardial effusion, 7(70%) female and 3(30%) male. In the positive culture group, from 10(58.8%) cases, death occurred in 2(20%) patients, and in the negative culture group, from 7(41.2%) cases, death occurred in 2(38.5%) patients. The sera and pericardium effusion of patients in showed anti-IgM to M. pneumoniae, M. pneumophilia, L. pneumophilia, C. pneumophilia, RSV, Adenovirus, Influenza A virus, and Influenza B virus antibodies. The results showed 7/17(41.2%) positive cases of pericarditis attributed to M. pneumoniae. In (17) patients with acute pericarditis admitted found 2/17(11.8%) positive cases detected by IFA in patients with L. pneumophilia. IFA revealed that 1/17(5.9%) of positive cases for the assay positive for Chlamydophila pneumoniae. Recent study revealed that the IFA detect 2/17 (11.8%) of cases positive for Adenovirus. Depending on IFA recent study identified 2/17(11.8%) cases with RSV associated with another etiological agents and present a case of Influenza A virus infection 1/17(5.9%). Our results showed a case with pericardial effusion positive for Influenza B virus 1/17(5.9%) associated with presence of RSV and L. pneumophilia in patient with intestinal cancer with negative results of bacterial culture media for both pericardial effusion and blood.



2020 ◽  
pp. 26-28
Author(s):  
I. A. Malchikov ◽  
A. V. Slobodenyuk ◽  
I. V. Vyalykh ◽  
A. Yu. Markaran ◽  
Yu. V. Grigorieva ◽  
...  

Donor blood serum was tested to detect antibodies against circulating influenza viruses. The titer of specific antibodies was determined in the hemagglutination inhibition test (RTGA) against influenza viruses A/California/07/09(H1N1) pdm09, A/HongKong/4801/14(H3N2) and B/Brisben/46/15. In the pre-epidemic period 2018–2019, the immune layer of people with conditionally protective titers of antiviral antibodies was detected in terms of the lowest to A(H3N2) virus (50.0 %), the highest to influenza B (85.4 %). In the post-epidemic season of 2018–2019, the immune layer to influenza A(H1N1) pdm09 virus did not change significantly, which could indicate the preservation of the activity of this virus in the adult population; an increase in the immune layer of individuals with protective titers of antibodies to influenza A(H3N2) – 67.4 % and a decrease in influenza B virus – 49.2 %. A comparison of the results of laboratory data carried out in the pre- and post-epidemic seasons revealed significant differences in the number of people with average antibody titers against influenza A(H3N2) and B viruses (p < 0.05).



2017 ◽  
Vol 16 (1) ◽  
pp. 7-15 ◽  
Author(s):  
A. A. Sominina ◽  
E. A. Smorodintseva ◽  
K. A. Stolyarov ◽  
A. A. Mel'nikova

Existing influenza surveillance system is constantly improved to obtain comprehensive information for understanding of continuously changing situation with the influenza, which is a consequence of the highest variability of the pathogen, its ability to reassortment and the imminence of emergence a new shift-variants of the virus that could cause the next pandemic events. For this purpose, since the 2010 - 2011 epidemic season, in addition to the traditional surveillance system (TS) a new well standardized sentinel surveillance system (SS) for rapid clinical and epidemiological data obtaining was introduced in Russia. A total 7812 hospitalized patients with severe acute respiratory infection (SARI) and 9854 outpatients with influenza-like illness and acute respiratory infection (ILI/ARI) were investigated during the 6-year period in SS. Percent of SARI among all hospitalized patients ranged from 1.7 to 3.1%; about 5.3 - 7.5% SARI patients were placed in the Intensive Care Unit. Etiological monitoring using PCR showed influenza spread trends in SS similar to those registered in the TS: a clear predominance of influenza A (H1N1) pdm09 among SARI and ILI/ARI in 2010 - 2011 and 2015 - 2016 epidemic seasons, influenza A (H3N2) in the epidemic seasons 2011 - 2012 and 2014 - 2015, the co-circulation of these pathogens in 2012 - 2013, 2013 - 2014 seasons in Russia. SARI caused by influenza B virus were detected less frequently than influenza A but increased influenza B activity was registered in the epidemic of 2014 -2015, when Yamagata lineage changed suddenly for the Victorian one. The average frequency of influenza diagnosis among SARI between the seasons varied in the range 12.5 - 27.1%, at the peak of the epidemic it reached 44.8 - 73.5% and was the highest during the season with active circulation of influenza A (H1N1) pdm09 virus. The rate of influenza diagnosis among ILI/ARI has always been lower than that among SARI. Studies have also shown the importance of rhinovirus, RS-virus and parainfluenza infections in SARI development. The frequency of registration of coronaviruses, metapneumovirus and bocavirus infection was very low in SARI and ILI/ARI. It was found that in all studied seasons most of SARI patients with influenza have not been vaccinated. Among ILI/ARI outpatients with influenza, the frequency of vaccinated individuals for the entire period of the study was estimated as 10.1%, which was 4.2 times higher than that in SARI, where only 2.4% of patients were vaccinated. In addition, it was found that for all six seasons the SARI patients with influenza were treated with antivirals drugs 2 times less often compared to outpatients. Analysis of data on concomitant diseases and conditions in SARI patients with influenza confirmed the leading role of pregnancy as a risk factor for hospitalization in all influenza epidemics, irrespective of their etiology. In addition, diabetes and cardiovascular disease were recognized as risk factors for influenza associated SARI development.



2020 ◽  
Vol 43 (3) ◽  
pp. 1-7
Author(s):  
Nattapol Narong ◽  
Siriwat Manajit ◽  
Sirikarn Athipanyasil ◽  
Niracha Athipanyasilp ◽  
Ruengpung Sutthent ◽  
...  

Background: Influenza A (pandemic and seasonal H1/H3) and influenza B viruses were the predominant circulating seasonal influenza strains. Following its massive outbreak in 2009 globally, including Thailand, influenza A (H1N1) pdm09 viruses have replaced the previous seasonal H1 strain and become one of the circulating strains ever since. Both influenza A and B viruses are highly contagious and potentially cause respiratory illness ranging from mild to severe. Objective: To determine the prevalence of types and subtypes of circulating influenza virus strains in Bangkok, Thailand during 2013 - 2017. Methods: The 4385 nasopharyngeal wash specimens were collected from patients presented with influenza-like illness from January 2013 to December 2017 at Siriraj Hospital, Bangkok, Thailand. Influenza virus types and subtypes were determined using real-time RT-PCR technique. Clinical characteristics of patients infected with influenza A viruses and influenza B virus were compared and analyzed. Results: Of 4385 nasopharyngeal wash specimens, the prevalence of influenza virus infection during 2013 - 2017 was 18.22% (n = 799). Of 799 influenza-positive samples, 608 (76.09%) and 191 (23.90%) samples were positive for influenza A and influenza B viruses, respectively. Most patients were presented with fever, cough, and runny nose; however, patients infected with influenza A virus generally had higher severity than those with influenza B virus infection (P < .05). Conclusions: The findings provided the characteristics of influenza virus types and subtypes at Siriraj Hospital, Bangkok, Thailand during 2013 - 2017. Sporadic cases of influenza occurred all year round, but the incidence peaked in March 2014 and August 2017. The outcomes of this study are potentially useful for prevention, treatment, and disease monitoring.  



Author(s):  
M.E. Ignat’eva ◽  
I.Yu. Samoilova ◽  
L.V. Budatsyrenova ◽  
T.V. Korita ◽  
O.E. Trotsenko

We analyzed the epidemiological situations on influenza and acute respiratory viral infections during the 2015–2016, 2016–2017 and 2017–2018 epidemic seasons in the Republic of Sakha (Yakutia). The 2015–2016 and 2016–2017 epidemic seasons differed from the previous ones by a rather high intensity of the epidemic process, moderate duration of the epidemic awareness with a two-wave pattern of the course, high morbidity of the population at the epidemic peak and the absence of the disease’s severe forms in those vaccinated against influenza. During the 2015–2016 epidemic season, the influenza A (H1N1) virus was the dominant pathogen in Yakutia. During the 2016–2017 epidemic season, the first morbidity awareness was caused by the influenza A (H3N2) virus, the second morbidity awareness was caused by the influenza B virus. In contrast to previous two seasons the 2017–2018 epidemic season is characterized by lower intensity, a significant morbidity decrease of influenza and acute respiratory viral infections in different age groups of the population and a low level of influenza viruses' circulation. Influenza A (H3N2) virus dominated and joined influenza B virus circulation was registered subsequently during the 2017–2018 epidemic season.



2017 ◽  
Vol 4 (4) ◽  
Author(s):  
Dominic E Dwyer ◽  
Ruth Lynfield ◽  
Marcelo H Losso ◽  
Richard T Davey ◽  
Alessandro Cozzi-Lepri ◽  
...  

Abstract Background Outcome data from prospective follow-up studies comparing infections with different influenza virus types/subtypes are limited. Methods Demographic, clinical characteristics and follow-up outcomes for adults with laboratory-confirmed influenza A(H1N1)pdm09, A(H3N2), or B virus infections were compared in 2 prospective cohorts enrolled globally from 2009 through 2015. Logistic regression was used to compare outcomes among influenza virus type/subtypes. Results Of 3952 outpatients, 1290 (32.6%) had A(H1N1)pdm09 virus infection, 1857 (47.0%) had A(H3N2), and 805 (20.4%) had influenza B. Of 1398 inpatients, 641 (45.8%) had A(H1N1)pdm09, 532 (38.1%) had A(H3N2), and 225 (16.1%) had influenza B. Outpatients with A(H1N1)pdm09 were younger with fewer comorbidities and were more likely to be hospitalized during the 14-day follow-up (3.3%) than influenza B (2.2%) or A(H3N2) (0.7%; P &lt; .0001). Hospitalized patients with A(H1N1)pdm09 (20.3%) were more likely to be enrolled from intensive care units (ICUs) than those with A(H3N2) (11.3%) or B (9.8%; P &lt; .0001). However, 60-day follow-up of discharged inpatients showed no difference in disease progression (P = .32) or all-cause mortality (P = .30) among influenza types/subtypes. These findings were consistent after covariate adjustment, in sensitivity analyses, and for subgroups defined by age, enrollment location, and comorbidities. Conclusions Outpatients infected with influenza A(H1N1)pdm09 or influenza B were more likely to be hospitalized than those with A(H3N2). Hospitalized patients infected with A(H1N1)pdm09 were younger and more likely to have severe disease at study entry (measured by ICU enrollment), but did not have worse 60-day outcomes.



2012 ◽  
Vol 27 (9) ◽  
pp. 1114 ◽  
Author(s):  
Sun Kim ◽  
Hwa Jin Cho ◽  
Dong Kyun Han ◽  
Yoo Duk Choi ◽  
Eun Seok Yang ◽  
...  


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Nungruthai Suntronwong ◽  
Sirapa Klinfueng ◽  
Sumeth Korkong ◽  
Preeyaporn Vichaiwattana ◽  
Thanunrat Thongmee ◽  
...  

AbstractWe monitored the circulating strains and genetic variation among seasonal influenza A and B viruses in Thailand between July 2017 and March 2020. The hemagglutinin gene was amplified and sequenced. We identified amino acid (AA) changes and computed antigenic relatedness using the Pepitope model. Phylogenetic analyses revealed multiple clades/subclades of influenza A(H1N1)pdm09 and A(H3N2) were circulating simultaneously and evolved away from their vaccine strain, but not the influenza B virus. The predominant circulating strains of A(H1N1)pdm09 belonged to 6B.1A1 (2017–2018) and 6B.1A5 (2019–2020) with additional AA substitutions. Clade 3C.2a1b and 3C.2a2 viruses co-circulated in A(H3N2) and clade 3C.3a virus was found in 2020. The B/Victoria-like lineage predominated since 2019 with an additional three AA deletions. Antigenic drift was dominantly facilitated at epitopes Sa and Sb of A(H1N1)pdm09, epitopes A, B, D and E of A(H3N2), and the 120 loop and 190 helix of influenza B virus. Moderate computed antigenic relatedness was observed in A(H1N1)pdm09. The computed antigenic relatedness of A(H3N2) indicated a significant decline in 2019 (9.17%) and 2020 (− 18.94%) whereas the circulating influenza B virus was antigenically similar (94.81%) with its vaccine strain. Our findings offer insights into the genetic divergence from vaccine strains, which could aid vaccine updating.



Author(s):  
Pınar YAZICI ÖZKAYA ◽  
Eşe Eda TURANLI ◽  
Hamdi METİN ◽  
Ayça Aydın UYSAL ◽  
Candan ÇİÇEK ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document